These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38767692)

  • 1. Investigation of colistin utilization in the treatment of multidrug-resistant gram-negative nosocomial bloodstream ınfections in children and literature review.
    Genis C; Kaman A; Öztürk B; Tanır G
    Eur J Pediatr; 2024 Aug; 183(8):3407-3415. PubMed ID: 38767692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
    Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
    Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?
    Ozsurekci Y; Aykac K; Cengiz AB; Bayhan C; Sancak B; Karadag Oncel E; Kara A; Ceyhan M
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):233-8. PubMed ID: 27041107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens.
    Yılmaz GR; Baştuğ AT; But A; Yıldız S; Yetkin MA; Kanyılmaz D; Akıncı E; Bodur H
    J Infect Chemother; 2013 Feb; 19(1):57-62. PubMed ID: 22806446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
    Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
    Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
    Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
    Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome.
    Dimitriades K; Morrow BM; Jeena P
    Arch Dis Child; 2014 Mar; 99(3):262-6. PubMed ID: 24170687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis.
    Karageorgos SA; Bassiri H; Siakallis G; Miligkos M; Tsioutis C
    J Antimicrob Chemother; 2019 Sep; 74(9):2497-2506. PubMed ID: 31049586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study.
    Almangour TA; Alruwaili A; Almutairi R; Alrasheed A; Alhifany AA; Eljaaly K; Alkofide H; Alhammad AM; Ghonem L; Alsharidi A
    Int J Infect Dis; 2021 Jul; 108():406-412. PubMed ID: 34111542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria.
    Iosifidis E; Violaki A; Michalopoulou E; Volakli E; Diamanti E; Koliouskas D; Antachopoulos C; Drossou-Agakidou V; Sdougka M; Roilides E
    J Pediatric Infect Dis Soc; 2017 Jun; 6(2):123-128. PubMed ID: 27000866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous colistin for the management of multidrug-resistant bacterial infections in Indian patients.
    Wilfred PM; Chandy SJ; Rebecca G; Satyendra S; Jasmine S
    Trop Doct; 2021 Jul; 51(3):301-306. PubMed ID: 33491607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant gram-negative bacteremia.
    Vicari G; Bauer SR; Neuner EA; Lam SW
    Clin Infect Dis; 2013 Feb; 56(3):398-404. PubMed ID: 23090926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of safety and efficacy of colistin use in pediatric intensive care unit: Results from two reference hospitals and review of literature.
    Sahbudak Bal Z; Kamit Can F; Yazici P; Berna Anil A; Duyu M; Yilmaz Ciftdogan D; Nisel Yilmaz O; Cilli F; Karapinar B
    J Infect Chemother; 2018 May; 24(5):370-375. PubMed ID: 29361414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients.
    Averbuch D; Horwitz E; Strahilevitz J; Stepensky P; Goldschmidt N; Gatt ME; Shapira MY; Resnick IB; Engelhard D
    Infection; 2013 Oct; 41(5):991-7. PubMed ID: 23653428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
    Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.